Trial Profile
Safety of Dasatinib in patients with Chronic Myeloid Leukaemia : A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Sep 2016
Price :
$35
*
At a glance
- Drugs Dasatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions
- 12 Sep 2016 New trial record